BioAffinity Technologies, Stock Forecast - Period Momentum Indicator
| BIAF Stock | USD 1.25 0.01 0.81% |
BioAffinity Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of BioAffinity Technologies,'s historical fundamentals, such as revenue growth or operating cash flow patterns.
BioAffinity |
| Check BioAffinity Technologies, Volatility | Backtest BioAffinity Technologies, | Information Ratio |
BioAffinity Technologies, Trading Date Momentum
| On November 22 2024 bioAffinity Technologies, was traded for 1.25 at the closing time. The top price for the day was 1.33 and the lowest listed price was 1.20 . There was no trading activity during the period 0.0. Lack of trading volume on November 22, 2024 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 0.80% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare BioAffinity Technologies, to competition |
Other Forecasting Options for BioAffinity Technologies,
For every potential investor in BioAffinity, whether a beginner or expert, BioAffinity Technologies,'s price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BioAffinity Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BioAffinity. Basic forecasting techniques help filter out the noise by identifying BioAffinity Technologies,'s price trends.BioAffinity Technologies, Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioAffinity Technologies, stock to make a market-neutral strategy. Peer analysis of BioAffinity Technologies, could also be used in its relative valuation, which is a method of valuing BioAffinity Technologies, by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
bioAffinity Technologies, Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of BioAffinity Technologies,'s price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of BioAffinity Technologies,'s current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BioAffinity Technologies, Market Strength Events
Market strength indicators help investors to evaluate how BioAffinity Technologies, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioAffinity Technologies, shares will generate the highest return on investment. By undertsting and applying BioAffinity Technologies, stock market strength indicators, traders can identify bioAffinity Technologies, entry and exit signals to maximize returns.
BioAffinity Technologies, Risk Indicators
The analysis of BioAffinity Technologies,'s basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioAffinity Technologies,'s investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bioaffinity stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.28 | |||
| Standard Deviation | 7.08 | |||
| Variance | 50.13 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether bioAffinity Technologies, is a strong investment it is important to analyze BioAffinity Technologies,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact BioAffinity Technologies,'s future performance. For an informed investment choice regarding BioAffinity Stock, refer to the following important reports:Check out Historical Fundamental Analysis of BioAffinity Technologies, to cross-verify your projections. For more detail on how to invest in BioAffinity Stock please use our How to Invest in BioAffinity Technologies, guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioAffinity Technologies,. If investors know BioAffinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioAffinity Technologies, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.91) | Revenue Per Share 0.744 | Quarterly Revenue Growth 120.474 | Return On Assets (0.70) | Return On Equity (1.52) |
The market value of bioAffinity Technologies, is measured differently than its book value, which is the value of BioAffinity that is recorded on the company's balance sheet. Investors also form their own opinion of BioAffinity Technologies,'s value that differs from its market value or its book value, called intrinsic value, which is BioAffinity Technologies,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioAffinity Technologies,'s market value can be influenced by many factors that don't directly affect BioAffinity Technologies,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioAffinity Technologies,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if BioAffinity Technologies, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioAffinity Technologies,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.